Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.0842 | 0.097 |
Echinococcus granulosus | RNA directed DNA polymerase | 0.0245 | 0.6615 | 0.6598 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0842 | 0.0797 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0842 | 0.0797 |
Brugia malayi | serine/threonine-protein kinase PAK 7 | 0.018 | 0.4404 | 0.533 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0842 | 0.0797 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.0842 | 0.097 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0842 | 0.0797 |
Brugia malayi | Protein kinase c protein 2 | 0.0292 | 0.8219 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0053 | 0.005 | 0.5 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.0842 | 0.1009 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0053 | 0.005 | 0.5 |
Echinococcus multilocularis | protein kinase c epsilon type | 0.0099 | 0.1604 | 0.1562 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0053 | 0.005 | 0.5 |
Loa Loa (eye worm) | AGC/PKC/ETA protein kinase | 0.0099 | 0.1604 | 0.1979 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.0842 | 0.1009 |
Loa Loa (eye worm) | hypothetical protein | 0.0245 | 0.6615 | 0.8361 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Echinococcus granulosus | protein kinase c epsilon type | 0.0099 | 0.1604 | 0.1562 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Echinococcus granulosus | protein kinase c iota type | 0.0091 | 0.1337 | 0.1293 |
Echinococcus granulosus | serine:threonine protein kinase PAK 4 | 0.0165 | 0.3879 | 0.3849 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Echinococcus multilocularis | serine threonine protein kinase | 0.0306 | 0.8713 | 0.8707 |
Echinococcus multilocularis | Protein kinase C, brain isozyme | 0.0344 | 1 | 1 |
Loa Loa (eye worm) | AGC/PKC/ALPHA protein kinase | 0.0254 | 0.6932 | 0.8765 |
Echinococcus granulosus | protein kinase C gamma type | 0.0306 | 0.8713 | 0.8707 |
Brugia malayi | protein kinase C II. | 0.0099 | 0.1604 | 0.1903 |
Echinococcus multilocularis | telomerase reverse transcriptase subunit | 0.0245 | 0.6615 | 0.6598 |
Entamoeba histolytica | protein kinase, putative | 0.0053 | 0.005 | 0.5 |
Loa Loa (eye worm) | STE/STE20/PAKB protein kinase | 0.018 | 0.4404 | 0.5545 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.0842 | 0.1009 |
Toxoplasma gondii | AGC kinase | 0.0053 | 0.005 | 0.5 |
Trypanosoma brucei | rac serine-threonine kinase, putative | 0.0053 | 0.005 | 0.5 |
Echinococcus multilocularis | protein kinase c iota type | 0.0091 | 0.1337 | 0.1293 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.0842 | 0.0797 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.0842 | 0.0797 |
Trichomonas vaginalis | AGC family protein kinase | 0.0053 | 0.005 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.0842 | 0.097 |
Echinococcus multilocularis | serine:threonine protein kinase PAK 4 | 0.0165 | 0.3879 | 0.3849 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0344 | 1 | 1 |
Schistosoma mansoni | atypical protein kinase C | 0.0091 | 0.1337 | 0.1293 |
Loa Loa (eye worm) | hypothetical protein | 0.0282 | 0.7902 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0099 | 0.1604 | 0.1562 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0344 | 1 | 1 |
Echinococcus multilocularis | RNA directed DNA polymerase | 0.0245 | 0.6615 | 0.6598 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.0842 | 0.0797 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 8.9125 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 67.4555 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.